Search research articles
Contact Us
Filters
Showing results (111-120 of 132) with videos related to
Page
of 14
Sort By:
Gynecologic Oncology
|
July 6, 2024
A toolkit for a modern gynecologic oncology tissue bank
Olivia Graham, Jeimmy Rodriguez, Rachel Abbott, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Cerebellum metastasis model of HER2-positive breast cancer unveils key role of IL34-induced Arg1+ macrophages
Xiaoqing Cheng, Khooshbu Kantibhai Patel, Brandon Zhou, et al.
NPJ Breast Cancer
|
January 7, 2023
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)
Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, et al.
Molecular Cancer Research : MCR
|
October 21, 2021
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress
Mary M Mullen, Elena Lomonosova, Michael D Toboni, et al.
Cancer Immunology Research
|
February 6, 2026
Neoadjuvant endocrine treatment plus mammaglobin-A DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of breast cancer patients: Insights from a phase 1b clinical trial
Rashmi Mishra, Foluso Ademuyiwa, Yilin Yang, et al.
Communications Biology
|
July 3, 2023
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival
Emilee N Kotnik, Mary M Mullen, Nicholas C Spies, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2025
Targeting RAD52 overcomes PARP inhibitor resistance in preclinical <i>Brca2</i>-deficient ovarian cancer model
Yukihide Ota, Vijayalaxmi Gupta, Bisiayo E Fashemi, et al.
Cancer Immunology Research
|
June 17, 2017
Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor Immunity
Xiuli Zhang, Samuel Kim, Jasreet Hundal, et al.
The Journal of Clinical Investigation
|
May 20, 2025
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Angela Schab, Amanda Compadre, Rebecca Drexler, et al.
Molecular Cancer Research : MCR
|
August 1, 2023
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins
Angela M Schab, Molly M Greenwade, Elizabeth Stock, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 132) with videos related to
Sort By:
Page
of 14
Gynecologic Oncology
|
July 6, 2024
A toolkit for a modern gynecologic oncology tissue bank
Olivia Graham, Jeimmy Rodriguez, Rachel Abbott, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Cerebellum metastasis model of HER2-positive breast cancer unveils key role of IL34-induced Arg1+ macrophages
Xiaoqing Cheng, Khooshbu Kantibhai Patel, Brandon Zhou, et al.
NPJ Breast Cancer
|
January 7, 2023
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)
Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, et al.
Molecular Cancer Research : MCR
|
October 21, 2021
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress
Mary M Mullen, Elena Lomonosova, Michael D Toboni, et al.
Cancer Immunology Research
|
February 6, 2026
Neoadjuvant endocrine treatment plus mammaglobin-A DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of breast cancer patients: Insights from a phase 1b clinical trial
Rashmi Mishra, Foluso Ademuyiwa, Yilin Yang, et al.
Communications Biology
|
July 3, 2023
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival
Emilee N Kotnik, Mary M Mullen, Nicholas C Spies, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2025
Targeting RAD52 overcomes PARP inhibitor resistance in preclinical <i>Brca2</i>-deficient ovarian cancer model
Yukihide Ota, Vijayalaxmi Gupta, Bisiayo E Fashemi, et al.
Cancer Immunology Research
|
June 17, 2017
Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor Immunity
Xiuli Zhang, Samuel Kim, Jasreet Hundal, et al.
The Journal of Clinical Investigation
|
May 20, 2025
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Angela Schab, Amanda Compadre, Rebecca Drexler, et al.
Molecular Cancer Research : MCR
|
August 1, 2023
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins
Angela M Schab, Molly M Greenwade, Elizabeth Stock, et al.
Page
of 14